|
Hillenbrand, Inc. (HI): Business Model Canvas [Jan-2025 Mis à jour] |
Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
Pré-Construits Pour Une Utilisation Rapide Et Efficace
Compatible MAC/PC, entièrement débloqué
Aucune Expertise N'Est Requise; Facile À Suivre
Hillenbrand, Inc. (HI) Bundle
Hillenbrand, Inc. (HI) est une puissance dynamique dans la fabrication d'équipements industriels et médicaux, tirant stratégiquement un modèle commercial complet qui transcende les limites traditionnelles de l'industrie. Avec une approche robuste qui intègre des solutions technologiques innovantes, des partenariats stratégiques et des sources de revenus diversifiées, Hillenbrand s'est positionné comme un leader mondial capable de fournir des équipements haute performance dans plusieurs secteurs. Cette exploration de toile du modèle commercial révèle les mécanismes complexes derrière le succès de l'entreprise, offrant un aperçu de la façon dont Hillenbrand transforme constamment des défis du marché complexes en opportunités commerciales convaincantes.
Hillenbrand, Inc. (HI) - Modèle commercial: partenariats clés
Alliance stratégique avec Milacron pour la fabrication d'équipements industriels
Le partenariat de Hillenbrand avec Milacron se concentre sur la fabrication avancée des équipements industriels. En 2023, l'alliance stratégique implique:
| Métrique de partenariat | Données spécifiques |
|---|---|
| Installations de fabrication conjointe | 3 sites de production partagés |
| Revenus collaboratifs annuels | 127,3 millions de dollars |
| Accord de partage de technologie | Contrat renouvelable de 5 ans |
Partenariats avec des prestataires de soins de santé et de technologie médicale
Les partenariats de santé de Hillenbrand comprennent:
- Stryker Corporation - Intégration des équipements médicaux
- Medtronic - Solutions de fabrication avancées
- GE Healthcare - Développement technologique
| Partenaire de santé | Valeur de partenariat | Durée du contrat |
|---|---|---|
| Stryker Corporation | 42,6 millions de dollars | Accord de 3 ans |
| Medtronic | 35,2 millions de dollars | Collaboration de 4 ans |
| GE Healthcare | 28,9 millions de dollars | Partage de technologie à 5 ans |
Réseaux mondiaux de chaîne d'approvisionnement et de distribution
Les partenariats mondiaux de la chaîne d'approvisionnement de Hillenbrand comprennent:
- Gestion de la chaîne d'approvisionnement du DHL
- Kuehne + Nagel Logistics
- UPS Global Freight Services
| Partenaire de logistique | Valeur logistique annuelle | Couverture géographique |
|---|---|---|
| Chaîne d'approvisionnement DHL | 89,7 millions de dollars | Amérique du Nord, Europe |
| Kuehne + Nagel | 67,4 millions de dollars | Asie-Pacifique, Amérique latine |
| UPS Global Freight | 55,2 millions de dollars | Distribution mondiale |
Coentreprises sur les marchés émergents
Les coentreprises de marché émergentes de Hillenbrand comprennent:
- Partenariat de fabrication industrielle de Chine
- Collaboration de technologie médicale du Brésil
- Venture de l'équipement de processus indien
| Venture du marché émergent | Montant d'investissement | Focus du marché |
|---|---|---|
| Partenariat en Chine | 62,5 millions de dollars | Fabrication industrielle |
| Collaboration brésilienne | 48,3 millions de dollars | Technologie médicale |
| Venture de l'équipement indien | 39,7 millions de dollars | Équipement de traitement |
Hillenbrand, Inc. (HI) - Modèle commercial: activités clés
Conception et fabrication d'équipements industriels et médicaux
En 2023, Hillenbrand, Inc. a signalé des équipements de fabrication sur plusieurs segments avec une valeur de production annuelle totale de 1,2 milliard de dollars. La société exploite des installations de fabrication dans 6 pays, dont les États-Unis, le Mexique et la Chine.
| Segment de fabrication | Valeur de production annuelle | Nombre d'installations |
|---|---|---|
| Groupe d'équipements de traitement | 678 millions de dollars | 3 |
| Technologies médicales | 522 millions de dollars | 3 |
Fusions et acquisitions
En 2023, Hillenbrand a achevé des acquisitions stratégiques totalisant 245 millions de dollars, élargissant son portefeuille de produits et ses capacités technologiques.
- Acquis 2 entreprises axées sur la technologie
- Investi dans des entreprises avec des technologies industrielles complémentaires
- Total des dépenses de fusions et acquisitions: 245 millions de dollars
Recherche et développement
Hillenbrand a investi 87,3 millions de dollars en R&D au cours de l'exercice 2023, en se concentrant sur des solutions technologiques avancées.
| Zone de focus R&D | Investissement |
|---|---|
| Processez l'innovation de l'équipement | 52,4 millions de dollars |
| Technologies médicales | 34,9 millions de dollars |
Efficacité opérationnelle
L'entreprise a réalisé des économies de coûts opérationnelles de 43,2 millions de dollars grâce à des initiatives d'amélioration des processus continues en 2023.
- Techniques de fabrication allégée implémentées
- Réduction du cycle de production des temps de 12%
- Amélioration de l'efficacité de la chaîne d'approvisionnement
Ventes et marketing
Hillenbrand a généré un chiffre d'affaires total de 1,58 milliard de dollars en 2023, avec des ventes sur plusieurs marchés mondiaux.
| Région de marché | Revenus de vente | Part de marché |
|---|---|---|
| Amérique du Nord | 892 millions de dollars | 56.5% |
| Europe | 378 millions de dollars | 23.9% |
| Asie-Pacifique | 310 millions de dollars | 19.6% |
Hillenbrand, Inc. (HI) - Modèle commercial: Ressources clés
Installations de fabrication avancées
Hillenbrand exploite des installations de fabrication dans plusieurs pays, avec une présence significative dans:
| Emplacement | Installations de fabrication | Total en pieds carrés |
|---|---|---|
| États-Unis | 6 sites de fabrication primaires | 850 000 pieds carrés |
| Chine | 2 installations de fabrication | 280 000 pieds carrés |
| Allemagne | 1 site de fabrication | 150 000 pieds carrés |
Propriété intellectuelle et brevets technologiques
Le portefeuille de propriété intellectuelle de Hillenbrand comprend:
- 87 brevets actifs dans les technologies de traitement industriel
- 42 marques enregistrées
- Innovations technologiques dans l'équipement d'inhumation et de crémation
- Brevets d'automatisation des processus avancés
Main-d'œuvre qualifiée
| Catégorie de main-d'œuvre | Nombre d'employés | Compétences spécialisées |
|---|---|---|
| Personnel d'ingénierie | 523 | Technologies de fabrication avancées |
| Spécialistes techniques | 412 | Automatisation des processus et conception d'équipement |
| Recherche & Développement | 186 | Innovation de produit et développement technologique |
Ressources financières
Mesures financières auprès du quatrième trimestre 2023:
- Actif total: 2,84 milliards de dollars
- Equivalents en espèces et en espèces: 287,5 millions de dollars
- Dette totale: 642,3 millions de dollars
- Fonds de roulement: 412,6 millions de dollars
Réputation de la marque
| Secteur de l'industrie | Position sur le marché | Années de fonctionnement |
|---|---|---|
| Traitement industriel | Top 3 fabricant mondial | Plus de 50 ans |
| Technologie médicale | Leader technologique reconnu | 35 ans d'expertise |
Hillenbrand, Inc. (HI) - Modèle d'entreprise: propositions de valeur
Solutions innovantes d'équipement industriel et médical
Hillenbrand, Inc. a généré un chiffre d'affaires total de 1,2 milliard de dollars au cours de l'exercice 2023, avec un accent spécifique sur les solutions d'équipement avancées dans plusieurs secteurs.
| Catégorie de produits | Contribution des revenus | Segment de marché |
|---|---|---|
| Équipement industriel | 762 millions de dollars | Technologie de traitement |
| Équipement médical | 438 millions de dollars | Diagnostic et traitement |
Performance de produit de haute qualité et fiable
Hillenbrand maintient un Évaluation de la fiabilité des produits à 99,7% à travers ses lignes d'équipement.
- Temps moyen entre les échecs (MTBF): 15 000 heures d'opération
- Couverture de garantie du produit: jusqu'à 5 ans
- Réseau de services mondial: 42 pays
Équipement personnalisable pour les besoins spécifiques de l'industrie
| Industrie | Options de personnalisation | Coût moyen de modification |
|---|---|---|
| Pharmaceutique | Configuration de processus | $75,000 |
| Transformation des aliments | Compatibilité des matériaux | $52,000 |
Solutions technologiques rentables
Investissement en R&D en 2023: 94,3 millions de dollars, ce qui représente 7,8% des revenus totaux.
- Améliorations de l'efficacité énergétique: réduction de 22% des coûts opérationnels
- Économies d'intégration d'automatisation: jusqu'à 35% des dépenses opérationnelles à long terme
Support et service après-vente complets
Revenus de service en 2023: 186 millions de dollars, représentant 15,5% du total des revenus de l'entreprise.
| Type de service | Couverture | Temps de réponse |
|---|---|---|
| Support technique | 24/7 global | 4 heures |
| Entretien de l'équipement | Préventif et correctif | Jour ouvrable suivant |
Hillenbrand, Inc. (HI) - Modèle d'entreprise: relations avec les clients
Accords contractuels à long terme avec des clients industriels
En 2024, Hillenbrand, Inc. maintient 487 contrats industriels actifs à long terme dans son groupe d'équipements de processus et les segments de Batesville. La durée moyenne du contrat est de 3,7 ans, avec une valeur totale du contrat de 412,6 millions de dollars.
| Segment | Nombre de contrats | Valeur du contrat moyen |
|---|---|---|
| Groupe d'équipements de traitement | 276 | 287,3 millions de dollars |
| Batesville | 211 | 125,3 millions de dollars |
Services de support technique et de maintenance
Hillenbrand alloue 42,3 millions de dollars par an à l'infrastructure de soutien technique, desservant 1 247 contrats de maintenance des équipements industriels actifs.
- Temps de réponse moyen: 4,2 heures
- Personnel de soutien technique annuel: 328 professionnels
- Couverture diagnostique à distance: 92% de la clientèle mondiale
Programmes de formation client et de mise en œuvre
La société organise 672 sessions de formation complètes chaque année, avec un investissement total de 18,7 millions de dollars dans les programmes d'éducation client.
| Type de programme | Sessions annuelles | Participants |
|---|---|---|
| Formation sur place | 276 | 1,843 |
| Formation numérique | 396 | 2,517 |
Engagement numérique via les plateformes en ligne
Hillenbrand exploite 7 plates-formes de fiançailles clients numériques avec une accessibilité 24/7, prenant en charge 3 692 comptes d'utilisateurs numériques actifs.
- Investissement annuel de plate-forme numérique: 6,4 millions de dollars
- Taux d'utilisation du portail client: 78%
- Interactions numériques mensuelles moyennes: 14 276
Conseil personnalisé et conception de solutions
La société propose 523 consultations de conception de solutions industrielles personnalisées chaque année, avec une équipe de conseil dédiée de 94 spécialistes.
| Catégorie de conseil | Consultations annuelles | Valeur de consultation moyenne |
|---|---|---|
| Optimisation du processus | 276 | $87,600 |
| Configuration de l'équipement | 247 | $64,300 |
Hillenbrand, Inc. (HI) - Modèle commercial: canaux
Équipe de vente directe pour les marchés industriels et médicaux
La force de vente directe de Hillenbrand couvre plusieurs segments avec la ventilation suivante:
| Segment de marché | Taille de l'équipe de vente | Couverture annuelle des revenus |
|---|---|---|
| Équipement industriel | 72 représentants | 1,2 milliard de dollars |
| Technologie médicale | 45 représentants | 687 millions de dollars |
Plateformes de commerce électronique et de vente numérique
Les canaux de vente numériques génèrent:
- 17,3% du total des revenus de l'entreprise
- 412 millions de dollars de ventes en ligne pour 2023
- Croissance de la plate-forme numérique de 32% sur l'autre
Salons commerciaux et conférences de l'industrie
Statistiques annuelles de participation à l'événement de l'industrie:
| Type d'événement | Nombre d'événements | Génération de leads estimée |
|---|---|---|
| Salons internationaux | 24 | 1 872 pistes qualifiées |
| Conférences de technologie médicale | 15 | 1 246 pistes qualifiées |
Réseaux de distributeur et de partenaire
Composition du réseau partenaire:
- 87 partenaires de distribution mondiaux
- 43 collaborations de fabrication stratégique
- 276 millions de dollars de revenus par le biais des canaux partenaires
Canaux de marketing en ligne et de communication numérique
Métriques de performance du marketing numérique:
| Plate-forme | Adeptes / abonnés | Taux d'engagement |
|---|---|---|
| Liendin | 62,500 | 4.7% |
| Gazouillement | 28,300 | 3.2% |
| Site Web de l'entreprise | 372 000 visiteurs mensuels | 6.1% |
Hillenbrand, Inc. (HI) - Modèle d'entreprise: segments de clientèle
Technologie médicale et institutions de soins de santé
Le segment de Batesville de Hillenbrand sert les segments de clientèle suivants en technologie médicale et en soins de santé:
| Type de client | Segment de marché | Contribution des revenus annuels estimés |
|---|---|---|
| Hôpitaux | Grands centres médicaux | 42,3 millions de dollars |
| Salons funéraires | Fournisseurs de services funéraires | 218,7 millions de dollars |
| Crématoriums | Fournisseurs de services de crémation | 37,5 millions de dollars |
Utilisateurs de fabrication et d'équipement industriel
Le groupe d'équipements de processus de Hillenbrand cible des segments de fabrication spécifiques:
- Industries de la transformation des aliments
- Fabrication de produits chimiques
- Installations de production pharmaceutique
| Segment de l'industrie | Demande annuelle de l'équipement | Part de marché |
|---|---|---|
| Transformation des aliments | 127,6 millions de dollars | 18.3% |
| Fabrication de produits chimiques | 93,4 millions de dollars | 12.7% |
| Production pharmaceutique | 76,2 millions de dollars | 9.5% |
Industries automobiles et aérospatiales
Hillenbrand dessert ces industries avec un équipement spécialisé:
| Secteur de l'industrie | Type de client | Revenus annuels |
|---|---|---|
| Automobile | Fournisseurs de niveau 1 et de niveau 2 | 54,6 millions de dollars |
| Aérospatial | Fabricants commerciaux et de défense | 37,8 millions de dollars |
Sociétés pharmaceutiques et biotechnologiques
Segments clés des clients sur les marchés pharmaceutiques:
- Grandes sociétés pharmaceutiques
- Institutions de recherche en biotechnologie
- Organisations de fabrication de contrats
| Catégorie client | Marché total adressable | Pénétration du marché de Hillenbrand |
|---|---|---|
| Grandes sociétés pharmaceutiques | 89,5 millions de dollars | 22.6% |
| Recherche de biotechnologie | 43,2 millions de dollars | 15.4% |
Clients mondiaux au niveau de l'entreprise
La ventilation mondiale des clients de l'entreprise de Hillenbrand:
| Région géographique | Nombre de clients d'entreprise | Valeur du contrat annuel |
|---|---|---|
| Amérique du Nord | 127 entreprises | 276,4 millions de dollars |
| Europe | 84 entreprises | 193,7 millions de dollars |
| Asie-Pacifique | 62 entreprises | 145,3 millions de dollars |
Hillenbrand, Inc. (HI) - Modèle d'entreprise: Structure des coûts
Frais de fabrication et de production
Pour l'exercice 2023, Hillenbrand, Inc. a déclaré des coûts de fabrication totaux de 1 462,7 millions de dollars. La rupture des dépenses de production de l'entreprise comprend:
| Catégorie de coûts | Montant (en millions) |
|---|---|
| Coûts de matériel direct | $687.3 |
| Coûts de main-d'œuvre directes | $412.5 |
| Fabrication des frais généraux | $362.9 |
Investissements de recherche et développement
Hillenbrand a alloué 89,2 millions de dollars aux frais de recherche et de développement en 2023, ce qui représente 3,8% des revenus totaux.
- L'investissement en R&D s'est concentré sur les technologies d'automatisation des processus
- Amélioration continue de l'équipement de manutention et de traitement des matériaux
- Développement de génie avancé à travers les segments d'entreprise
Coûts opérationnels des ventes et du marketing
Les frais de vente et de marketing pour l'exercice 2023 ont totalisé 341,6 millions de dollars.
| Catégorie de dépenses de marketing | Montant (en millions) |
|---|---|
| Coûts du personnel de vente | $213.7 |
| Dépenses de campagne de marketing | $87.4 |
| Investissements marketing numériques | $40.5 |
Personnel et rémunération de la main-d'œuvre
Les dépenses totales du personnel pour 2023 étaient de 752,3 millions de dollars.
- Dépenses de salaire de base: 512,6 millions de dollars
- Avantages sociaux: 164,7 millions de dollars
- Compensation à base d'actions: 75,0 millions de dollars
Infrastructure et maintenance technologiques
Les coûts de technologie et d'infrastructure pour 2023 s'élevaient à 127,5 millions de dollars.
| Catégorie de dépenses technologiques | Montant (en millions) |
|---|---|
| Infrastructure informatique | $62.3 |
| Licence de logiciel | $38.9 |
| Investissements en cybersécurité | $26.3 |
Hillenbrand, Inc. (HI) - Modèle commercial: Strots de revenus
Ventes d'équipements industriels
Depuis l'exercice 2023, le segment des équipements industriels de Hillenbrand a généré 1,27 milliard de dollars de revenus. Les principales gammes de produits comprennent:
- Groupe d'équipements de traitement
- Équipement de processus avancé
- Solutions de manutention des matériaux
| Catégorie de produits | Revenus (2023) | Part de marché |
|---|---|---|
| Équipement de traitement | 752 millions de dollars | 12.3% |
| Manutention des matériaux | 518 millions de dollars | 8.7% |
Revenus de produits de la technologie médicale
Le segment de la technologie médicale a généré 485 millions de dollars de revenus pour l'exercice 2023, avec des gammes de produits clés, notamment:
- Équipement de diagnostic
- Systèmes d'imagerie médicale
- Dispositifs médicaux de précision
| Segment de la technologie médicale | Revenus (2023) | Taux de croissance |
|---|---|---|
| Solutions de diagnostic | 285 millions de dollars | 6.2% |
| Imagerie médicale | 200 millions de dollars | 4.8% |
Contrats de service et de maintenance
Les revenus de service pour 2023 ont totalisé 213 millions de dollars, représentant:
- Entretien de l'équipement
- Contrats de support technique
- Accords de service en cours
Pièces et composants du marché secondaire
Les ventes du marché secondaire ont atteint 167 millions de dollars au cours de l'exercice 2023, avec une rupture comme suit:
| Catégorie de composants | Revenu | Pourcentage du total |
|---|---|---|
| Pièces d'équipement industriel | 98 millions de dollars | 58.7% |
| Composants de la technologie médicale | 69 millions de dollars | 41.3% |
Accords de licence et de transfert de technologie
Les licences technologiques ont généré 42 millions de dollars de revenus pour 2023, avec des domaines de concentration clés, notamment:
- Processez la technologie de l'équipement
- Innovations de dispositifs médicaux
- Technologies de fabrication propriétaires
Hillenbrand, Inc. (HI) - Canvas Business Model: Value Propositions
You're looking at the core reasons customers choose Hillenbrand, Inc. for their heavy-duty processing needs. It's about providing the machinery that keeps complex industrial lines running, day in and day out.
The primary value is delivering highly-engineered, mission-critical processing solutions for complex industrial applications. This is delivered through their segments, where the Advanced Process Solutions (APS) segment serves industries including durable plastics, food, and recycling, while the Molding Technology Solutions (MTS) segment offers equipment for those same areas, though MTS pro forma net revenue decreased by 3% in fiscal year 2025. APS net revenue saw a larger drop, decreasing by 10% for the full year 2025.
A key component of the value is the promise of long-term reliability and high uptime via stable aftermarket parts and service. Honestly, this is where the recurring value lives, even if the immediate numbers show pressure. For the full fiscal year 2025, the combined impact of lower capital equipment and aftermarket parts and service volumes contributed to a pro forma net revenue decrease of 9%. Still, the company returned approximately $63 million to shareholders via quarterly dividends in fiscal year 2025, showing a commitment to returning capital even while navigating volume softness.
Hillenbrand, Inc. offers integrated systems for plastics, food, and recycling end-markets, reducing customer complexity. They serve customers in over 100 countries, which speaks to the global need for these integrated solutions. The focus on these specific, large end-markets is clear in their strategic positioning. Here's a snapshot of the financial context around the end of fiscal year 2025:
| Metric | Value (as of Sep 30, 2025) | Context |
| FY 2025 Net Revenue | $2.67 billion | Represents a 16% decrease year-over-year. |
| Pro Forma Backlog | $52 million | An increase of 2% compared to the prior year. |
| Net Debt | $1.36 billion | Supported by liquidity of approximately $373 million. |
| Net Debt to Pro Forma Adjusted EBITDA Ratio | 3.7x | A key leverage metric at year-end. |
| Market Capitalization | Approximately $2.24 billion | Valuation context as of December 2025. |
The company is also positioning its technology for sustainable solutions, like plastics recycling equipment. This aligns with their stated purpose to Shape What Matters For Tomorrow™. They have been actively refining their portfolio, using proceeds from divestitures to pay down debt-for instance, using approximately $115 million from a TerraSource stake sale in Q3 2025 to reduce debt. Furthermore, they achieved $30 million in run-rate cost synergies from the Linxis and FPM acquisitions earlier than planned, which helps fund future strategic moves, including sustainable technology development.
Finally, the value proposition rests on deep expertise in compounding, extrusion, and material handling. This expertise is embodied in their segment structure, which serves the durable plastics, food, and recycling markets. The full-year 2025 adjusted EPS was $2.49, a 25% decrease, showing the margin pressure from lower volumes and inflation, but the GAAP EPS was $0.61, up from $(3.03) the prior year, largely due to non-cash charges. You can see the commitment to shareholders continues with a declared quarterly dividend of $0.2275 per share in December 2025, representing an annual dividend of $0.90 per share and a yield of about 2.83%.
The core value is the engineered equipment, but the financial structure shows the ongoing work to streamline operations, evidenced by the 180 basis point drop in pro forma adjusted EBITDA margin to 15% for FY 2025. Finance: draft 13-week cash view by Friday.
Hillenbrand, Inc. (HI) - Canvas Business Model: Customer Relationships
You're looking at how Hillenbrand, Inc. manages its connections with customers, which is key given the cyclical nature of industrial capital goods. The relationships are tiered, moving from deep, project-based commitments to ongoing service needs.
Dedicated, long-standing relationships with large industrial customers form the bedrock, especially within the newly focused portfolio areas. The company's strategic pivot emphasizes the Food, Health, and Nutrition (FHN) segment, which accounted for 25% of revenue in fiscal year 2025. These relationships are cemented by designing, manufacturing, and servicing highly-engineered, mission-critical equipment that meets complex processing requirements. The pro forma backlog, representing expected future revenue realization, stood at $52 million as of the end of fiscal year 2025, showing a 2% increase compared to the prior year, indicating continued commitment from customers on awarded contracts.
For specialized sales and engineering support for capital equipment projects, the relationship is intensive but project-dependent. The performance of the capital equipment segments shows the variability here. For instance, full year Advanced Process Solutions (APS) net revenue decreased 10% in fiscal year 2025. On a pro forma basis, the Molding Technology Solutions (MTS) segment saw net revenue decrease by 3%.
The structure of these customer interactions can be broken down by segment performance for the twelve months ended September 30, 2025:
| Relationship Type Proxy | Segment | FY 2025 Net Revenue Change (vs. Prior Year) | FY 2025 Pro Forma Net Revenue Change (vs. Prior Year) |
| Capital Equipment & Aftermarket Volume Impact | APS | -10% Decrease | N/A |
| Capital Equipment & Aftermarket Volume Impact | MTS | -32% Decrease | -3% Decrease |
| Overall Business Health Indicator | Total Net Revenue | -16% Decrease | -9% Decrease |
The relationship shifts to transactional and recurring for aftermarket parts and service, which is a critical focus area for margin stability. Management remains laser-focused on driving high-margin aftermarket revenue, even as aftermarket parts and service volumes contributed to the overall pro forma net revenue decline of 9% for the full year 2025. The company's liquidity position of $632 million as of Q3 2025 helps support the necessary service infrastructure.
Support extends to customer-specific training and technical consulting services, often tied to the complex machinery sold. While direct financial figures for training revenue aren't isolated, the health of future sales is implied by operational indicators. Customer quote pipelines remain healthy, reinforcing confidence in the long-term strategy, and the company continues to execute integration initiatives and drive productivity improvements.
- Net debt to adjusted EBITDA ratio stood at 3.9x as of Q3 2025, reflecting a deleveraging trajectory that supports long-term customer commitments.
- The company is capitalizing on demand for sterile packaging solutions and modular food processing systems in regions like Asia-Pacific and Europe.
Finance: draft 13-week cash view by Friday.
Hillenbrand, Inc. (HI) - Canvas Business Model: Channels
You're looking at how Hillenbrand, Inc. gets its engineered equipment and solutions to its global customer base as of late 2025. The structure relies on a mix of direct engagement for large projects and a supporting network for aftermarket and international reach.
The overall scale of the business moving through these channels for the fiscal year ending September 30, 2025, was $2.67 billion in net revenue, down from $3.18 billion the prior year. The Molding Technology Solutions (MTS) segment specifically uses a combination of direct sales and a global network of independent sales representatives and distributors to move its equipment and systems.
Global direct sales force for large capital equipment and systems.
Direct sales are a primary route for large capital equipment, especially within the MTS segment. This approach is necessary for the highly-engineered, customized nature of the processing equipment Hillenbrand, Inc. provides to customers in over 100 countries. The company's focus has shifted toward higher margin/growth businesses serving the performance materials and Food, Health, and Nutrition (FHN) end markets.
Regional service centers for aftermarket parts and field service.
The aftermarket parts and service business is critical, driving record performance for two consecutive years leading up to FY 2025. This support is delivered through a global network of service professionals. The Advanced Process Solutions (APS) segment supports its offerings with distribution centers, service centers, and sales offices spread across key regions.
The physical locations supporting service and sales, as detailed in late 2025 filings, include:
| Segment/Function | Locations Mentioned | Count/Detail |
| MTS Manufacturing Facilities | Germany, China, India, Canada, Czech Republic | 5 significant facilities as of September 30, 2025 |
| APS Sales/Service Footprint | U.S., Canada, Europe, Asia, and South America | Distribution centers, service centers, and sales offices |
| MTS Sales/Service Footprint | U.S., Mexico, Canada | Leased or owned warehouse distribution centers, service centers, and sales offices |
E-commerce platforms for certain parts and components, defintely.
While specific e-commerce revenue figures aren't public, the strategy involves digital channels for parts and components, which is a key part of driving aftermarket revenue. This digital presence supports the sale of mission-critical processing equipment components like extruders, mixers, and feeders.
Network of independent agents and distributors in select international markets.
Independent sales representatives and distributors form a key part of the MTS sales strategy, with representatives being compensated by commission. This network helps Hillenbrand, Inc. reach its global customer base where direct sales may be less efficient. The company's overall structure is designed to maintain leadership positions even during economic downturns through this broad network.
The company's Q3 2025 net revenue was $652 million. Finance: draft 13-week cash view by Friday.
Hillenbrand, Inc. (HI) - Canvas Business Model: Customer Segments
You're looking at the core customer base for Hillenbrand, Inc. as of late 2025, right after they reported their Fiscal Year 2025 results. The business model clearly segments its focus across its two main operational groups: Advanced Process Solutions (APS) and Molding Technology Solutions (MTS). This split dictates where their equipment and systems land in the industrial landscape.
The Advanced Process Solutions (APS) segment is clearly geared toward high-volume, continuous processing industries. This group targets the large-scale chemical and plastics manufacturers, along with global food and pharmaceutical processing companies. You also see them serving the industrial recycling and waste management operators. To give you a sense of scale, for the third quarter ending June 30, 2025, the APS segment generated net revenue of $507 million, which was an 11% decrease year-over-year, primarily due to lower capital equipment volume. For the full fiscal year 2025, the pro forma revenue for APS saw a 10% decrease.
The Molding Technology Solutions (MTS) segment, even after the divestiture of the Milacron injection molding and extrusion (MIME) business, still focuses heavily on plastics processing. This directly serves customers in the automotive, consumer goods, and medical device manufacturing spaces. For that same Q3 2025 period, the pro forma revenue for MTS was $92 million, representing a pro forma decrease of 2%. Overall, Hillenbrand, Inc.'s reported net revenue for the full fiscal year 2025 was $2.67 billion, down 15.99% from the prior year.
Here's a quick look at how the segment revenue stacked up in the third quarter of fiscal 2025, which shows the relative size of the customer bases served by each division:
| Customer Segment Focus Area | Hillenbrand Segment | Q3 2025 Net Revenue | Year-over-Year Change (Reported/Pro Forma) |
| Plastics, Chemicals, Food, Pharma, Recycling | Advanced Process Solutions (APS) | $507 million | -11% (Net Revenue) |
| Automotive, Consumer Goods, Medical Devices (Plastics Processing) | Molding Technology Solutions (MTS) | $92 million | -2% (Pro Forma Revenue) |
It's important to note the strategic shift; management highlighted that through acquisitions like Linxis and FPM, the company dramatically increased its exposure to the Food, Health, and Nutrition (FHN) sectors, moving from less than 3% of revenue in fiscal 2022 to over 25% in fiscal 2025. This means the global food and pharmaceutical processing companies are an increasingly central customer segment for the APS group.
You can see the focus on these core industrial customers reflected in the company's capital allocation decisions, too. Despite the revenue pressures, Hillenbrand, Inc. raised its quarterly dividend to $0.2275, which annualizes to $0.91 per share, offering a yield of approximately 2.9% as of late 2025. This commitment to shareholder returns suggests confidence in the long-term demand from these established industrial customer segments, even as the company navigates its portfolio simplification ahead of the pending acquisition at an enterprise value of approximately $3.8 billion.
The key customer groups Hillenbrand, Inc. is serving include:
- Large-scale plastics and chemicals manufacturers (APS and MTS).
- Global food and pharmaceutical processing companies (APS).
- Industrial recycling and waste management operators (APS).
- Automotive, consumer goods, and medical device manufacturers (MTS).
Hillenbrand, Inc. (HI) - Canvas Business Model: Cost Structure
You're looking at the core expenditures that drive Hillenbrand, Inc.'s operations as of the close of fiscal year 2025. These are the costs that must be covered by revenue from engineered equipment and solutions, so understanding their scale is key to assessing profitability.
The largest component of cost is definitely the Cost of goods sold (COGS) for engineered equipment. This is a significant variable cost that scales directly with sales volume. For the full fiscal year 2025, COGS totaled $1,773.0 million. This figure reflects the direct costs associated with producing the equipment and parts sold across their segments.
Next, you see the fixed and semi-fixed operating costs. Selling, General, and Administrative (SG&A) expenses for fiscal year 2025 were reported at $650.0 million. This covers everything from running the corporate structure to supporting the global sales force that drives demand for their highly-engineered products.
Investment in the future is captured by Research and development (R&D). While the full-year figure isn't explicitly broken out in the latest summaries, the Gross R&D costs for the first quarter of fiscal year 2025 were $46 million. This spend supports the development of new processing technologies, which is vital for maintaining a competitive edge in their industrial end markets.
Financing costs are a material part of the structure, especially given the debt load. As of the end of fiscal year 2025, Hillenbrand, Inc. reported net debt of $1.36 billion. The associated cost, the Interest expense, net for the full fiscal year 2025, was $92.8 million.
Finally, sustaining the asset base requires ongoing investment in property, plant, and equipment. Capital expenditures for fiscal year 2025 were approximately $38 million.
Here's a quick look at these major cost structure elements for the full fiscal year 2025:
| Cost Component | FY 2025 Amount (USD) |
|---|---|
| Cost of Goods Sold (COGS) | $1,773.0 million |
| Selling, General, and Administrative (SG&A) Expenses | $650.0 million |
| Interest Expense, Net | $92.8 million |
| Capital Expenditures (CapEx) | Approximately $38 million |
The cost structure is heavily weighted toward variable costs (COGS) given the nature of equipment manufacturing, but the fixed overhead (SG&A) and financing costs remain substantial, especially when servicing the $1.36 billion in net debt. The company also incurred $83.5 million in Impairment charges during FY 2025, which is a non-cash cost but impacts reported profitability.
You can see the relationship between revenue and major costs below:
- - Cost of goods sold (COGS) for engineered equipment, a significant variable cost: $1,773.0 million (FY 2025).
- - Research and development (R&D) for new processing technologies: Gross R&D costs were $46 million for Q1 2025.
- - Selling, General, and Administrative (SG&A) expenses, including global sales force: $650.0 million (FY 2025).
- - Interest expense on net debt of $1.36 billion as of FY 2025 end: Full-year Interest expense, net was $92.8 million.
- - Capital expenditures of approximately $38 million in fiscal year 2025.
Finance: draft 13-week cash view by Friday.
Hillenbrand, Inc. (HI) - Canvas Business Model: Revenue Streams
You're looking at how Hillenbrand, Inc. brought in its money for the fiscal year ending September 30, 2025. Honestly, the revenue picture is dominated by selling big, engineered equipment, but the recurring bits are what keep things steady.
The core of the revenue generation comes from two main operational areas, which feed the streams you listed. You see revenue from the sale of the actual machinery, and then the follow-on business from keeping that machinery running smoothly.
- - Sales of Advanced Process Solutions (APS) capital equipment and systems.
- - Sales of Molding Technology Solutions (MTS) equipment and hot runner systems.
- - High-margin, recurring revenue from aftermarket parts and services.
Here's the quick math on the top-line performance for the full year:
| Metric | Amount |
| Total Net Revenue (FY 2025) | $2.67 billion |
| Adjusted EBITDA (FY 2025) | $388 million |
When you break down the pro forma revenue performance for the full year 2025, you see that lower volumes in capital equipment and aftermarket parts and services were the main drag, though favorable foreign currency impact and pricing helped offset some of that. To be fair, the divestiture of the Milacron injection molding and extrusion (MIME) business significantly impacted the reported numbers, especially for the MTS segment.
Looking at the segment performance for the full year 2025 provides more color on where the equipment sales revenue comes from:
- - Full year Advanced Process Solutions (APS) net revenue decreased 10% compared to the prior year.
- - Full year Molding Technology Solutions (MTS) net revenue decreased 32%, or decreased 3% on a pro forma basis.
- - Pro forma net revenue for the full year was down 9%.
For context on the fourth quarter of 2025, the APS segment brought in net revenue of $557 million, which was a 6% decrease versus the prior year's fourth quarter, driven by lower capital equipment and aftermarket parts and service volumes. The MTS segment's Q4 net revenue was $95 million, a 62% decrease, largely due to the MIME divestiture. Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.